Every person who gets cancer
deserves a better answer.
For the hardest cancers, the ones that return after treatment, the ones that cannot be operated on, conventional medicine runs out of answers. That is not inevitable. It is a gap. BNCT closes it.
The vision of BNCT Global is not just a network of centers. It is a world where growing older does not mean running out of options.
“The goal is to grow old. Together.”
The reach
One center draws a circle. Millions live inside it.
The reason
We cannot keep getting older
and accept that this means
getting cancer.
Aging is the single greatest cancer risk factor. Not lifestyle. Not genetics. Age. By 2050, the world will have more people over 60 than at any point in human history.
For patients who have exhausted every option, the conventional path ends. That is not inevitable. It is a gap that exists because the infrastructure to close it was never built.
BNCT Global exists because one person decided that was not acceptable. Prof. Sauerwein has spent decades building the scientific and clinical relationships that make a global network possible. Not a plan on paper. A network of people, institutions, and governments ready to act.
The vision is not abstract. It is a standard of care, established in Europe and carried outward. As far as the technology allows. To as many people as can be reached.
From partnership to patients. Three stages.
Partnership and planning
- Regional government or institution confirms partnership.
- Site assessment, regulatory planning, equipment specification.
- BNCT Global provides the full blueprint.
Clinical trials and reimbursement
- First patients treated under controlled clinical protocol.
- Data collected across the network. Reimbursement applications filed.
- The BNCT Global standard ensures your data contributes to the whole.
Full operation
- Reimbursement approved. Center operates at full capacity.
- 1,500 patients per year within reach. The standard is set.
What one center means for your region.
BNCT centers integrate into existing hospital infrastructure. No new buildings, no new departments. One accelerator room added to an existing oncology center.
Unlike conventional radiotherapy where the care network must be distributed, a single BNCT center draws patients from across the region for a single session.
Japan has already approved and reimburses BNCT for head and neck cancer since 2020. The European trial data will follow the same regulatory structure.
Hosting a BNCT Therapy Center positions a medical institution as a European reference site, accelerating referrals and clinical partnerships across indications.
“A region that hosts a BNCT center does not just gain a treatment option. It gains a decade of clinical leadership in precision oncology.”
Interested in hosting a Therapy Center?
Prof. Sauerwein meets directly with regional health ministries and hospital leadership.
Start a conversationThe science was always right.
Now the technology is ready.
BNCT Global is coordinating the clinical, regulatory, and investment infrastructure to bring BNCT to European patients. The next center could be yours.